HomeLarge Type Edition
HOME ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:1270-1276 (2004)
© 2004 The Gerontological Society of America

EDITORIAL

Flying Through 5 Years

John E. Morley

Division of Geriatric Medicine, Saint Louis University, and Geriatric Research Education and Clinical Center, VA Medical Center, St. Louis, Missouri.

Address correspondence to John E. Morley, MB, BCh, Division of Geriatric Medicine, Saint Louis University School of Medicine, 1402 S. Grand Blvd., M238, St. Louis, MO 63104. E-mail: jgeronmed{at}slu.edu

"I can do anything now at age 90 that I could do when 18, which shows how pathetic I was at 18."

—George Burns

I have had the tremendous privilege of serving the readers of the Journal of Gerontology: Medical Sciences as their Editor for the last 5 years. The Journal has been fortunate in receiving an extraordinarily strong set of articles from contributors. This has allowed the Journal to enhance its reputation as shown by the growth in its impact factor [Figure 1; see (1) for definitions]. Only the Neurobiology of Aging now has a better impact factor in the category of geriatrics and gerontology (Table 1). In addition, the Journal has the highest immediacy index.



View larger version (25K):
[in this window]
[in a new window]
  		Figure 1. Impact factor for Journal of Gerontology: Medical Sciences for 1999–2003

 

View this table:
[in this window]
[in a new window]
  		Table 1. Impact Factors for The Journals of Gerontology Series A for 2003 as Listed in the JCR Scientific Edition as of June 24, 2004.

 
Over the last 5 years, we have made a number of improvements to the readability of the Journal. This has included editorials that have concentrated on placing the original articles in the context of the developing field of geriatrics, as seen through the eyes of the Journal [e.g., (2–10)]. Occasionally we have tried to highlight the overall emerging areas in gerontology such as in the Top 10 Hot Topics in Geriatrics (11,12). This, for instance, allowed us to highlight the good, the bad, and the ugly of the rapidly emerging area of anti-aging medicine (13–16). We introduced a series of review articles originally highlighting clinical topics, but, more recently, concentrating on some of the basic science foundations of geriatrics (17–22). My own favorite has been the Future History series, where authors have skillfully blended the past with the future of geriatrics (23,24). We introduced target articles, accompanied by commentaries such as those on geriatrics as a chronic hospital specialty (25), to treat or not to treat hypertension in the old-old (26–28), the role of insulin resistance in dementia (29), and the future of longevity (30). These articles certainly created a spirited response and dialogue (27,31–37). Finally, the introduction of letters has allowed authors to defend their work (38,39).

From the 2001 list of citations (Table 2), Linda Fried and her colleagues' article giving an objective definition of frailty was the most highly cited article (40). This definition has now become the gold standard for research in the frailty arena. In 2004, Fried and colleagues updated the concepts of frailty, disability, and comorbidity in the Journal (41). In 2001, 16 of the 46 highly cited articles involved nutrition, 6 addressed hormones and aging, 6 physical activity, and 5 centenarians/longevity.


View this table:
[in this window]
[in a new window]
  		Table 2. Most Cited Articles for the Year 2001 in The Journals of Gerontology Series A.

 
In 2002, 32 articles were cited 10 or more times (Table 3), and the review article on andropause was the most cited article (17). Testosterone replacement therapy in older males has become a major controversial issue in geriatrics, as shown by the numerous other articles on testosterone among the most cited list, and the fact that the Journal continues to publish articles on the testosterone controversy in 2004 (42–44). Three further articles on frailty made the highly cited list for 2002. Anti-aging also began to become an important topic in 2002 (13–16) and continues this year as shown by the series of anti-aging articles published in the Journal of Gerontology: Biological Sciences (45–62) and in a full issue of Clinics in Geriatrics (63–74) in 2004.


View this table:
[in this window]
[in a new window]
  		Table 3. Most Cited Articles for the Year 2002 in The Journals of Gerontology Series A.

 
Sarcopenia began to appear as a major issue in 2002, and the series reviewing sarcopenia that appeared in the Journal toward the end of 2003 has already started to be highly cited (75–82). In 2004, an article in the Journal suggested an important role for the vitamin D receptor genotype in the pathogenesis of sarcopenia (83).

For 2003, Blazer's review on depression and Wittert and colleagues' article on testosterone replacement have already been very highly cited (Table 4) (84,85). In 2003, 32 articles were cited 5 or more times. An extraordinarily important article from this year is the one by Colcombe and colleagues (86) highlighting the relationship of aerobic fitness to brain tissue loss. The series of articles on mobility is already beginning to be highly cited (87–94).


View this table:
[in this window]
[in a new window]
  		Table 4. Most Cited Articles for the Year 2003 in The Journal of Gerontology Series A.

 
Among the 3 years of citations, a number of articles have highlighted the growing importance of cytokines in the production of sarcopenia, frailty, and death in older persons (95). The Journal continues to publish articles in this area (96–102). An editorial has characterized this occurrence as the Cytokine-Related Aging Process (103).

Articles within 2004 that are starting to occasion interest are the three on delirium (104–106) and the highlighting of the role of the insulin resistance syndrome in aging (18,107). My own favorite article for 2004 was by Tamura and colleagues (108), which utilized an entertainment robot for the care of older persons with cognitive dysfunction. This is in keeping with the earlier emphasis in the Journal on putting the "home" back in nursing homes (109) and utilizing pet therapy (110) and the Eden Alternative (111). An innovation in 2004 was to begin to publish the Joseph T. Freeman award lectures (112). Finally, I trust that our readers obtained pleasure from the Brief History of Geriatrics and the oral (written) histories associated with it (113–131).

My 5 years of stewardship of the Journal has provided me with tremendous enjoyment. I trust the readers have enjoyed the changes as much as I have. To maintain the quality of the Journal and the rapid review time (17 days to first decision in the first 6 months of 2004) has meant that a dedicated cadre of gerontologists have served as reviewers and on the editorial board. To these unsung heroes of journal production, I would particularly like to say thank you. My four associate editors, David Thomas, Joseph Flaherty, Larry Johnson, and Pam Cacchione, have provided extraordinary advice and managed the Journal on my frequent trips out of town. They deserve a hearty round of applause both from me and our readers. The staff in the Society's office, Patty Walker and Jennifer Campi, have provided solid support. My thanks also go to the Publications Committee members who have provided encouragement and support during my experimentation with changes in the Journal. My greatest gratitude goes to my assistant editor, Valerie Rincker. It is Val who saw that the manuscripts flowed smoothly. She was the foundation on which the Journal's success was built. From the bottom of my heart, I thank you, Val.

Finally, I congratulate Luigi Ferrucci on being selected as the next editor of the Journal. I trust that he, too, will be blessed with continuing to receive the outstanding quality of articles submitted to the Journal. The Journal is now truly the premier clinical geriatric journal. I have no question that Dr. Ferrucci will take the Journal of Gerontology: Medical Sciences to even greater heights. As the poet said, "Grow old along with me, the best is yet to be."

References

  1. Morley JE. Highly cited papers in the journals. J Gerontol Med Sci. 2003;58A:1098-1102.
  2. Morley JE, Flaherty JH, Thomas DR. Geriatricians, continuous quality improvement, and improved care for older persons. J Gerontol Med Sci. 2003;58A:809-812.
  3. Thomas DR. Anemia and quality of life: unrecognized and undertreated. J Gerontol Med Sci. 2004;59A:238-241.
  4. Flaherty JH, Stalvey B, Rubenstein L. A consensus statement on nonemergent medical transportation services for older persons. J Gerontol Med Sci. 2003;58A:M826-M831.
  5. Wilson MM. Urinary incontinence: bridging the gender gap. J Gerontol Med Sci. 2003;58A:752-755.
  6. Morley JE, Perry HM, III. Androgens and women at the menopause and beyond. J Gerontol Med Sci. 2003;58A:M409-M416.
  7. Asthana S. Estrogen and cognition: the story so far. J Gerontol Biol Sci. 2003;58A:322-323.
  8. Barzilai N. Discovering the secrets of successful longevity. J Gerontol Med Sci. 2003;58A:225-226.
  9. Salerno JA, Nagy C. Terrorism and aging. J Gerontol Med Sci. 2002;57A:M552-M554.
  10. Morley JE. A fall is a major event in the life of an older person. J Gerontol Med Sci. 2002;57A:M492-M495.
  11. Morley JE. Hot topics in geriatrics. J Gerontol Med Sci. 2003;58A:30-36.
  12. Morley JE. Drugs, aging, and the future. J Gerontol Med Sci. 2002;57A:M2-M6.
  13. Olshansky SJ, Hayflick L, Carnes BA. Position statement on human aging. J Gerontol Biol Sci. 2002;57A:B292-B297.
  14. Morley JE, Perry HM. Androgens and women at the menopause and beyond. J Gerontol Med Sci. 2003;58A:409-416.
  15. Butler RN, Fossel M, Harman SM, et al. Is there an antiaging medicine? J Gerontol Biol Sci. 2002;57A:B333-B338.
  16. Fisher A, Morley JE. Antiaging medicine: the good, the bad, and the ugly. J Gerontol Med Sci. 2002;57A:M636-M639.
  17. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol Med Sci. 2002;57A:M76-M99.
  18. Meneilly GS, Tessier D. Diabetes in elderly adults. J Gerontol Med Sci. 2001;56A:M5-M13.
  19. Singh MA. Exercise comes of age: rationale and recommendations for a geriatric exercise prescription. J Gerontol Med Sci. 2002;57A:M262-M282.
  20. Blumenthal HT. The aging-disease dichotomy: true or false? J Gerontol Med Sci. 2003;58A:138-145.
  21. Michel JP, Pautex S, Zekry D, Zuliani G, Gold G. End-of-life care of persons with dementia. J Gerontol Med Sci. 2002;57A:M640-M644.
  22. Poon HF, Calabrese V, Scapagnini G, Butterfield DA. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol Med Sci. 2004;59A:478-493.
  23. Qureshi H. Social and political influences on services for older people in the United Kingdom in the late 20th century. J Gerontol Med Sci. 2002;57A:M705-M711.
  24. Gutierrez-Robledo LM. Looking at the future of geriatric care in developing countries. J Gerontol Med Sci. 2002;57A:M162-M167.
  25. Kane RL. The future history of geriatrics: geriatrics at the crossroads. J Gerontol Med Sci. 2002;57A:M803-M805.
  26. Aronow WS. What is the appropriate treatment of hypertension in elders? J Gerontol Med Sci. 2002;57A:M483-M486.
  27. Goodwin JS. Embracing complexity: a consideration of hypertension in the very old. J Gerontol Med Sci. 2003;58A:653-658.
  28. Aronow WS. Commentary on "Embracing complexity: a consideration of hypertension in the very old.". J Gerontol Med Sci. 2003;58A:659-660.
  29. Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. J Gerontol Med Sci. 2004;59A:178-183.
  30. Robine JM, Michel JP. Looking forward to a general theory on population aging. J Gerontol Med Sci. 2004;59A:M590-M597.
  31. Hazzard WR. Geriatrics at the crossroads—or simply early in the journey? [Commentary]. J Gerontol Med Sci. 2002;57A:M806.
  32. Warshaw G. Commentary on Kane's "The future history of geriatrics: geriatrics at the crossroads.". J Gerontol Med Sci. 2002;57A:M806-M807.
  33. Rodin MB. Commentary on Kane's "The future history of geriatrics: geriatrics at the crossroads.". J Gerontol Med Sci. 2002;57A:M807-M808.
  34. Flaherty JH. The adolescence of geriatrics [Commentary]. J Gerontol Med Sci. 2002;57A:M808-M811.
  35. Tangalos EG. Commentary on Kane's "The future history of geriatrics: geriatrics at the crossroads. J Gerontol Med Sci. 2002;57A:M811.
  36. Sinclair AJ. Commentary on Kane's "The future history of geriatrics: geriatrics at the crossroads.". J Gerontol Med Sci. 2002;57A:M811-M812.
  37. Michel J-P, Pils K, Sieber C. Commentary on Kane's "The future history of geriatrics: geriatrics at the crossroads. J Gerontol Med Sci. 2002;57A:M812-M813.
  38. Blazer DG, Hybels CF, Pieper CF. Reply to Letter to the Editor by Rozzini et al. Response to "The association of depression and mortality in elderly persons.". J Gerontol Med Sci. 2002;57A:M144-M145.
  39. Kenny AM, Prestwood K, Iannuzzi-Sucich M. Authors' response to letter to the editor, "Preemptive strike?: sarcopenia and nutritional intervention" by Wilson MG. J Gerontol Med Sci. 2003;58A:673-674.
  40. Fried LP, Tangen CM, Walston J, et al.,for the Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol Med Sci. 2001;56A:M146-M157.
  41. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol Med Sci. 2004;59A:255-263.
  42. Asthana S, Bhasin S, Butler RN, et al. Masculine vitality: pros and cons of testosterone in treating the andropause. J Gerontol Med Sci. 2004;59A:461-465.
  43. Morley JE. The need for a men's health initiative. J Gerontol Med Sci. 2003;58A:614-617.
  44. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol Med Sci. 2001;56A:M266-M272.
  45. Hayflick L. "Antiaging" is an oxymoron. J Gerontol Biol Sci. 2004;59A:B573-B578.
  46. Holliday R. The multiple and irreversible causes of aging. J Gerontol Biol Sci. 2004;59A:B568-B572.
  47. Butler RN, Sprott R, Warner H, et al. Biomarkers of aging: from primitive organisms to humans. J Gerontol Biol Sci. 2004;59A:B560-B567.
  48. Stock G, Callahan D. Point-counterpoint: would doubling the human life span be a net positive or a negative for us either as individuals or as a society? J Gerontol Biol Sci. 2004;59A:B554-B559.
  49. Holliday R. The close relationship between biological aging and age-associated pathologies in humans. J Gerontol Biol Sci. 2004;59A:B543-B546.
  50. Binstock RH. Anti-aging medicine and research: a realm of conflict and profound societal implications. J Gerontol Biol Sci. 2004;59A:B523-B533.
  51. Olshansky SJ, Hayflick L, Perls TT. The hype and the reality—part I. J Gerontol Biol Sci. 2004;59A:B513-B514.
  52. Robert L. The three avenues of gerontology: from basic research to clinical gerontology and anti-aging medicine. Another French paradox. J Gerontol Biol Sci. 2004;59A:B540-B542.
  53. Post SG. Establishing an appropriate ethical framework: the moral conversation around the goal of prolongevity. J Gerontol Biol Sci. 2004;59A:B534-B539.
  54. Haber C. Life extension and history: the continual search for the fountain of youth. J Gerontol Biol Sci. 2004;59A:B515-B522.
  55. Olshansky SJ, Hayflick L, Perls TT. Introduction. Anti-aging medicine: the hype and the reality—Part II. J Gerontol Biol Sci. 2004;59A:649-651.
  56. Harman SM, Blackman MR. Use of growth hormone for prevention or treatment of effects of aging. J Gerontol Biol Sci. 2004;59A:652-658.
  57. Dangour AD, Sibson VL, Fletcher AE. Micronutrient supplementation in later life: limited evidence for benefit. J Gerontol Biol Sci. 2004;59A:659-673.
  58. Reisman NR. Legal issues associated with the current and future practice of anti-aging medicine. J Gerontol Biol Sci. 2004;59A:674-681.
  59. Perls TT. Anti-aging quackery: human growth hormone and tricks of the trade—more dangerous than ever. J Gerontol Biol Sci. 2004;59A:682-691.
  60. Warner HR. Current status of efforts to measure and modulate the biological rate of aging. J Gerontol Biol Sci. 2004;59A:692-696.
  61. Arking R, Novoseltsev V, Novoseltseva J. The human life span is not that limited: the effect of multiple longevity phenotypes. J Gerontol Biol Sci. 2004;59A:697-704.
  62. Rattan SIS. Aging intervention, prevention, and therapy through hormesis. J Gerontol Biol Sci. 2004;59A:705-709.
  63. Flaherty JH, Morley JE. Preface—Anti-aging. Clin Geriatr Med. 2004;20:XI-XV.
  64. Gammack JK, Morley. Anti-aging medicine—the good, the bad, and the ugly. Clin Geriatr Med. 2004;20:157-178.[Medline]
  65. Flaherty JH, Takahashi R. The use of complementary and alternative medical therapies among older persona round the world. Clin Geriatr Med. 2004;20:179-200.[Medline]
  66. Singh MAG. Exercise and aging. Clin Geriatr Med. 2004;20:201-222.[Medline]
  67. Killinger LZ. Chiropractic and geriatrics: a review of the training, role, and scope of chiropractic in caring for aging patients. Clin Geriatr Med. 2004;20:223-236.[Medline]
  68. Tariq SH. Herbal therapies. Clin Geriatr Med. 2004;20:237-258.[Medline]
  69. Thomas DR. Vitamins in health and aging. Clin Geriatr Med. 2004;20:259-274.[Medline]
  70. Horani MH, Morley JE. Hormonal fountains of youth. Clin Geriatr Med. 2004;20:275-292.[Medline]
  71. Hajjar RR. Cancer in the elderly: is it preventable? Clin Geriatr Med. 2004;20:293-316.[Medline]
  72. Banks WA, Farr SA. Antiaging methods and medicines for the memory. Clin Geriatr Med. 2004;20:317-328.[Medline]
  73. Poon HF, Calabrese V, Scapagnini G, Butterfield DA. Free radicals and brain aging. Clin Geriatr Med. 2004;20:329-360.[Medline]
  74. Fisher AL, Hill R. Ethical and legal issues in antiaging medicine. Clin Geriatr Med. 2004;20:361-366.[Medline]
  75. Yarasheski KE. Exercise, aging, and muscle protein metabolism. J Gerontol Med Sci. 2003;58A:918-922.
  76. Morley JE. Sarcopenia revisited. J Gerontol Med Sci. 2003;58A:909-910.
  77. Barton E, Morris C. Mechanisms and strategies to counter muscle atrophy. J Gerontol Med Sci. 2003;58A:923-926.
  78. Marcell TJ. Sarcopenia: causes, consequences and preventions. J Gerontol Med Sci. 2003;58A:911-916.
  79. Bhasin S. Testosterone supplementation for aging-associated sarcopenia. J Gerontol Med Sci. 2003;58A:1002-1008.
  80. Hawkins SA, Wiswell RA, Marcell TJ. Exercise and the master athlete—a model of successful aging? J Gerontol Med Sci. 2003;58A:1009-1011.
  81. Leeuwenburgh C. Role of apoptosis in sarcopenia. J Gerontol Med Sci. 2003;58A:999-1001.
  82. Roubenoff R. Sarcopenia: effects on body composition and function. J Gerontol Med Sci. 2003;58A:1012-1017.
  83. Roth SM, Zmuda JM, Cauley JA, Shea PR, Ferrell RE. Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol Med Sci. 2004;59A:10-15.
  84. Blazer DG. Depression in late life: review and commentary. J Gerontol Med Sci. 2003;58A:249-265.
  85. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol Med Sci. 2003;58A:618-625.
  86. Colcombe SJ, Erickson KI, Raz N, et al. Aerobic fitness reduces brain tissue loss in aging humans. J Gerontol Med Sci. 2003;58A:176-180.
  87. Morley JE. Mobility performance: a high-tech test for geriatricians. J Gerontol Med Sci. 2003;58A:712-714.
  88. Newman AB, Haggerty CL, Kritchevsky SB, Nevitt MC, Simonsick EM. Walking performance and cardiovascular response: associations with age and morbidity—the health, aging and body composition study. J Gerontol Med Sci. 2003;58A:715-720.
  89. Lan TY, Deeg DJH, Guralnik JM, Melzer D. Responsiveness of the index of mobility limitation: comparison with gait speed alone in the longitudinal aging study Amsterdam. J Gerontol Med Sci. 2003;58A:721-727.
  90. Thomas DR. The relationship between functional status and inflammatory disease in older adults. J Gerontol Med Sci. 2003;58A:995-998.
  91. Bean JF, Leveille SG, Kiely DK, Bandinelli S, Guralnik JM, Ferrucci L. A comparison of leg power and leg strength within the InCHIANTI Study: which influences mobility more? J Gerontol Med Sci. 2003;58A:728-733.
  92. Alexander NB, Dengel DR, Olson RJ, Krajewski KM. Oxygen-uptake (VO2) kinetics and functional mobility performance in impaired older adults. J Gerontol Med Sci. 2003;58A:734-739.
  93. Cesari M, Penninx BWJH, Pahor M, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol Med Sci. 2004;59A:242-248.
  94. Brandon LJ, Gaasch DA, Boyette LW, Lloyd AM. Effects of long-term resistive training on mobility and strength in older adults with disabetes. J Gerontol Med Sci. 2003;58A:740-745.
  95. Yeh SS, Wu SY, Levine DM, Parker TS, Olson JS, Stevens MR, Schuster MW. The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients. J Gerontol Med Sci. 2001;56A:M48-M54.
  96. Cesari M, Penninx BWJH, Lauretani F, et al. Hemoglobin levels and skeletal muscle: results from the InCHIANTI study. J Gerontol Med Sci. 2004;59A:249-254.
  97. Zuliani G, Cherubini A, Atti AR, et al. Low cholesterol levels are associated with short-term mortality in older patients with ischemic stroke. J Gerontol Med Sci. 2004;59A:293-297.
  98. Roth SM, Schrager MA, Lee MR, Metter EJ, Hurley BF, Ferrell RE. Interleukin-6 (IL6) genotype is associated with fat-free mass in men but not women. J Gerontol Biol Sci. 2003;58A:B1085-B1088.
  99. Lambert CP, Sullivan DH, Evans WJ. Effects of testosterone replacement and/or resistance training on interleukin-6, tumor necrosis factor alpha, and leptin in elderly men ingesting megestrol acetate: a randomized controlled trial. J Gerontol Med Sci. 2003;58A:165-170.
  100. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol Med Sci. 2002;57A:M326-M332.
  101. Blain H, Abdelmouttaleb I, Belmin J, et al. Arterial wall production of cytokines in giant cell arteritis: results of a pilot study using human temporal artery cultures. J Gerontol Med Sci. 2002;57A:M241-M245.
  102. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur Studies of Successful Aging. J Gerontol Med Sci. 2000;55A:M709-M715.
  103. Morley JE, Baumgartner RN. Cytokine-related aging process. J Gerontol Med Sci. 2004;59A:924-929.
  104. Flaherty JH, Morley JE. Delirium: a call to improve current standards of care. J Gerontol Med Sci. 2004;59A:341-343.
  105. Kiely DK, Bergmann MA, Jones RN, Murphy KM, Orav EJ, Marcantonio ER. Characteristics associated with delirium persistence among newly admitted post-acute facility patients. J Gerontol Med Sci. 2004;59A:344-349.
  106. Bourdel-Marchasson I, Vincent S, Germain C, et al. Delirium symptoms and low dietary intake in older inpatients are independent predictors of institutionalization: a 1-year prospective population-based study. J Gerontol Med Sci. 2004;59A:350-354.
  107. Morley JE. The metabolic syndrome and aging. J Gerontol Med Sci. 2004;59A:139-142.
  108. Tamura T, Yonemitsu S, Itoh A, et al. Is an entertainment robot useful in the care of elderly people with severe dementia? J Gerontol Med Sci. 2004;59A:83-85.
  109. Morley JE, Flaherty JH. Putting the "home" back in nursing home. J Gerontol Med Sci. 2002;57A:M419-M421.
  110. Banks MR, Banks WA. The effects of animal-assisted therapy on loneliness in an elderly population in long-term care facilities. J Gerontol Med Sci. 2002;57A:M428-M432.
  111. Coleman MT, Looney S, O'Brien J, Ziegler C, Pastorino CA, Turner C. The Eden alternative: findings after 1 year of implementation. J Gerontol Med Sci. 2002;57A:M422-M427.
  112. Rubenstein LZ, Joseph T. Freeman award lecture—comprehensive geriatric assessment: from miracle to reality. J Gerontol Med Sci. 2004;59A:473-477.
  113. Morley JE. A brief history of geriatrics [History]. J Gerontol Med Sci. 2004;59A:1132-1152.
  114. Achenbaum WA. Commentary [Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1153.
  115. Beck JC. Musings of an emeritus [Commentary on Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1154-1155.
  116. Blazer DG. Longitudinal studies on aging and the development of geriatrics in North America [Commentary on Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1155-1156.
  117. Blumenthal HT. Commentary [Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1156-1158.
  118. Butler RN. Commentary [Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1158-1159.
  119. Caplan GA, O'Sullivan R. A history to look forward from [Commentary on Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1159.
  120. Cooney LM, Jr. The evolution of American geriatrics [Commentary on Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1159-1160.
  121. Vellas B, Franco A, Forette B, Forette F. Commentary [Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1171-1172.
  122. Grimley-Evans J. Geriatrics in the United Kingdom: what happened next [Commentary on Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1160-1161.
  123. Hazzard WR. Geriatrics: specialty, subspecialty or supraspecialty [Commentary on Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1161-1162.
  124. Jarvik L. Commentary [Morley's "A brief history of geriatrics]. J Gerontol Med Sci. 2004;59A:1162-1163.
  125. Kressig RW, Gold G, Michel JP. European initiatives and future fields of interest in geriatric medicine. [Commentary on Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1163-1165.
  126. Libow LS. The first geriatric residency–fellowship in the United States [Commentary on Morley's "A brief history of geriatrics]. J Gerontol Med Sci. 2004;59A:1165-1166.
  127. Ribera-Casado JM. The history of geriatrics: a model for equity [Commentary on Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1166-1167.
  128. Sasaki H. Geriatrics and older people in Japan [Commentary on Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1167-1168.
  129. Steel K. Geriatrics—a profession in the making [Commentary on Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1168-1169.
  130. Tangalos EG. Notes of an organization watcher [Commentary on Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1169-1170.
  131. Williams TF. Commentary [Morley's "A brief history of geriatrics"]. J Gerontol Med Sci. 2004;59A:1170-1171.
  132. Bartke A, Coschigano K, Kopchick J, et al. Genes that prolong life: relationships of growth hormone and growth to aging and life span. J Gerontol Biol Sci. 2001;56A:B340-B349.
  133. Morley JE. Decreased food intake with aging. J Gerontol Biol Sci Med Sci. 2001;56A:(Spec Issue II): 81-88.
  134. Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol Med Sci. 2001;56A:M158-M166.
  135. Miller RA, Galecki A, Shmookler-Reis RJ. Interpretation, design, and analysis of gene array expression experiments. J Gerontol Biol Sci. 2001;56A:B52-B57.
  136. Gillick M. Pinning down frailty. J Gerontol Med Sci. 2001;56A:M134-M135.
  137. Mathey MFAM, Siebelink E, de Graaf C, Van Staveren WA. Flavor enhancement of food improves dietary intake and nutritional status of elderly nursing home residents. J Gerontol Med Sci. 2001;56A:M200-M205.
  138. Morley JE. Andropause: is it time for the geriatrician to treat it? J Gerontol Med Sci. 2001;56A:M263-M265.
  139. Blazer DG, Hybels CF, Pieper CF. The association of depression and mortality in elderly persons: a case for multiple, independent pathways. J Gerontol Med Sci. 2001;56A:M505-M509.
  140. Keysor JJ, Jette AM. Have we oversold the benefit of late-life exercise? J Gerontol Med Sci. 2001;56A:M412-M423.
  141. Beharka AA, Meydani M, Wu D, Leka LS, Meydani A, Meydani SN. Interleukin-6 production does not increase with age. J Gerontol Biol Sci. 2001;56A:B81-B88.
  142. Weindruch R, Keenan KP, Carney JM, et al. Caloric restriction mimetics: metabolic interventions. J Gerontol Biol Sci Med Sci. 2001;56A:(Spec Issue I): 20-33.
  143. Lal SB, Ramsey JJ, Monemdjou S, Weindruch R, Harper ME. Effects of caloric restriction on skeletal muscle mitochondrial proton leak in aging rats. J Gerontol Biol Sci. 2001;56A:B116-B122.
  144. Reynish W, Andrieu S, Nourhashemi F, Vellas B. Nutritional factors and Alzheimer's Disease. J Gerontol Med Sci. 2001;56A:M675-M680.
  145. Wakimoto P, Block G. Dietary intake, dietary patterns, and changes with age: an epidemiological perspective. J Gerontol Biol Sci Med Sci. 2001;56A:(Spec Issue II): 65-80.
  146. Wagner G, Montorsi F, Auerbach S, Collins M. Sildenafil citrate (VIAGRA®) improves erectile function in elderly patients with erectile dysfunction: a subgroup analysis. J Gerontol Med Sci. 2001;56A:M113-M119.
  147. Hortobagyi T, Tunnel D, Moody J, Beam S, DeVita P. Low- or high-intensity strength training partially restores impaired quadriceps force accuracy and steadiness in aged adults. J Gerontol Biol Sci. 2001;56A:B38-B47.
  148. Martin JA, Buckwalter JA. Telomere erosion and senescence in human articular cartilage chondrocytes. J Gerontol Biol Sci. 2001;56A:B172-B179.
  149. Singh NA, Clements KM, Singh MAF. The efficacy of exercise as a long-term antidepressant in elderly subjects: a randomized, controlled trial. J Gerontol Med Sci. 2001;56A:M497-M504.
  150. Frisoni GB, Louhija J, Geroldi C, Trabucchi M. Longevity and the E-2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol Med Sci. 2001;56A:M75-M78.
  151. Campbell WW, Trappe TA, Wolfe RR, Evans WJ. The recommended dietary allowance for protein may not be adequate for older people to maintain skeletal muscle. J Gerontol Med Sci. 2001;56A:M373-M380.
  152. Pollack M, Leeuwenbrugh C. Apoptosis and aging: role of the mitochondria. J Gerontol Biol Sci. 2001;56A:B475-B482.
  153. Roberts SB, Pi-Sunyer X, Kuller L, Lane MA, Ellison P, Prior JC, Shapses S. Physiologic effects of lowering caloric intake in nonhuman primates and nonobese humans. J Gerontol Biol Sci Med Sci. 2001;56A:(Spec Issue I): 66-75.
  154. Anisimov VN, Zavarzina NY, Zabezhinski MA, Popovich IG, Zimina OA, Shtylick AV, Arutjunyan AV, Oparina TI, Prokopenko VM, Mikhalski AI, Yashin AI. Melatonin increases both life span and tumor incidence in female CBA mice. J Gerontol Biol Sci. 2001;56A:B311-B323.
  155. King AC. Interventions to promote physical activity by older adults. J Gerontol Biol Sci Med Sci. 2001;56A:(Spec Issue II): 36-46.
  156. Maggi S, Minicuci N, Langlois J, Pavan M, Enzi G, Crepaldi G. Prevalence rate of urinary incontinence in community-dwelling elderly individuals: The Vento Study. J Gerontol Med Sci. 2001;56A:M14-M18.
  157. Simmons SF, Osterweil, Schnelle JF. Improving food intake in nursing home residents with feeding assistance: a staffing analysis. J Gerontol Med Sci. 2001;56A:M790-M794.
  158. Westerterp KR, Meijer EP. Physical activity and parameters of aging: a physiological perspective. J Gerontol Biol Sci Med Sci. 2001;56A:(Spec Issue II): 71-72.
  159. Zuliani G, Romagnoni F, Volpato S, et al. Nutritional parameters, body composition, and progression of disability in older disabled residents living in nursing homes. J Gerontol Med Sci. 2001;56A:M212-M216.
  160. Chernoff R. Nutrition and health promotion in older adults. J Gerontol Biol Sci Med Sci. 2001;56A:(Spec Issue II): 47-53.
  161. Hughes VA, Frontera WR, Wood M, Evans WJ, Dallal GE, Roubenoff R, Singh MAF. Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol Biol Sci. 2001;56A:B209-B217.
  162. Mobbs CV, Bray GA, Atkinson RL, et al. Neuroendocrine and pharmacological manipulations to assess how caloric restriction increases life span. J Gerontol Biol Sci Med Sci. 2001;56A:(Spec Issue I): 34-44.
  163. Amarantos E, Martinez A, Dwyer J. Nutrition and quality of life in older adults. J Gerontol Med Sci. 2001;56A:54-64.
  164. Arai Y, Hirose N, Yamamura K, Shimizu KI, Takayama M, Ebihara Y, Osono Y. Serum insulin-like growth factor-1 in centenarians: implications of IGF-1 as a rapid turnover protein. J Gerontol Med Sci. 2001;56A:M79-M82.
  165. Aronow WS. Treatment of older persons with hypercholesterolemia with and without cardiovascular disease. J Gerontol Med Sci. 2001;56A:M138-M145.
  166. Barzilai N, Chuldiner AR. Searching for human longevity genes: the future history of gerontology in the post-genomic era. J Gerontol Med Sci. 2001;56A:M83-M87.
  167. Gill J, Allum JHJ, Carpenter MG, et al. Trunk sway measures of postural stability during clinical balance tests: effects of age. J Gerontol Med Sci. 2001;56A:M438-M447.
  168. Rejeski WJ, Mihalko Sl. Physical activity and quality of life in older adults. J Gerontol Biol Sci Med Sci. 2001;56A:(Spec Issue II): 23-35.
  169. Simonsick EM, Newman AB, Nevitt MC, et al. Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC Study. J Gerontol Med Sci. 2001;56A:M644-M649.
  170. Castano G, Mas R, Fernandez JC, Illnait J, Fernandez L, Alvarez E. Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk. J Gerontol Med Sci. 2001;56A:M186-M192.
  171. Miller RA. Biomarkers of aging: prediction of longevity by using age-sensitive T-cell subset determinations in a middle-aged, genetically heterogeneous mouse population. J Gerontol Biol Sci. 2001;56A:B180-B186.
  172. Grune T, Shringarpure R, Sitte N, Davies K. Age-related changes in protein oxidation and proteolysis in mammalian cells. J Gerontol Biol Sci. 2001;56A:B459-B467.
  173. Perls T. Genetic and phenotypic markers among centenarians. J Gerontol Med Sci. 2001;56A:M67-M70.
  174. Bortz WM, II. A conceptual framework of frailty: a review. J Gerontol Med Sci. 2002;57A:M283-M288.
  175. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-{alpha} with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol Med Sci. 2002;57A:M326-M332.
  176. Morley JE, Perry HM, Miller DK. Something about frailty. J Gerontol Med Sci. 2002;57A:M698-M704.
  177. Christmas C, O'Connor KG, Harman SM, et al. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. J Gerontol Med Sci. 2002;57A:M12-M18.
  178. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol Med Sci. 2002;57A:M772-M777.
  179. Walford RL, Mock D, Verdery R, MacCallum. Calorie restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in human restricted for a 2-year period. J Gerontol Biol Sci. 2002;57A:B211-B224.
  180. Lipsitz LA. Dynamics of stability: the physiological basis of functional health and frailty. J Gerontol Biol Sci. 2002;57A:B115-B125.
  181. Hubert HB, Bloch DA, Oehlert JW, Fries JF. Lifestyle habits and compression of morbidity. J Gerontol Med Sci. 2002;57A:M347-M351.
  182. Kenny AM, Bellantonio S, Gruman CA, Acosta RD, Prestwood KM. Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol Med Sci. 2002;57A:M321-M325.
  183. Aronow WS, Ahn C, Gutstein H. Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dl treated with statins versus no lipid-lowering drug. J Gerontol Med Sci. 2002;57A:M333-M335.
  184. Aronow WS. Should hypercholesterolemia in older persons be treated to reduce cardiovascular events? J Gerontol Med Sci. 2002;57A:M411-M413.
  185. Cypser JR, Johnson TE. Multiple stressor in caenorrhabditis elegans induce stress hormesis and extended longevity. J Gerontol Biol Sci. 2002;57A:B109-B114.
  186. Zamboni M, Zoico E, Tosoni P, et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol Med Sci. 2002;57A:M7-M11.
  187. Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol Biol Sci. 2002;57A:B359-B365.
  188. Aronow WS, Ahn C, Gutstein H. Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a long-term health care facility. J Gerontol Med Sci. 2002;57A:M45-M46.
  189. Morley JE, Flaherty JH. It's never too late: health promotion and illness prevention in older persons. J Gerontol Med Sci. 2002;57A:M338-M342.
  190. Petitti DB, Buckwalter JG, Crooks VC, Chiu V. Prevalence of dementia in users of hormone replacement therapy as defined by prescription data. J Gerontol Med Sci. 2002;57A:M532-M538.
  191. Simmons SF, Babineau S, Garcia E, Schnelle JF. Quality assessment in nursing homes by systematic direct observation: feeding assistance. J Gerontol Med Sci. 2002;57A:M665-M671.
  192. Evans WJ. Exercise as the standard of care for elderly people. J Gerontol Med Sci. 2002;57A:M260-M261.
  193. Hajjar I, Miller K, Hirth V. Age-related bias in the management of hypertension: a national survey of physicians' opinions on hypertension in elderly adults. J Gerontol Med Sci. 2002;57A:M487-M491.
  194. Liu LJ, Bopp MM, Roberson PK, Sullivan DH. Undernutrition and risk of mortality in elderly patients within 1 year of hospital discharge. J Gerontol Med Sci. 2002;57A:M741-M746.
  195. Carter CS, Ramsey MM, Ingram RL, et al. Models of growth hormone and IGF-1 deficiency: applications to studies of aging processes and life-span determination. J Gerontol Biol Sci. 2002;57A:B177-B188.
  196. Lan TY, Melzer D, Tom BDM, Guralnik JM. Performance tests and disability: developing an objective index of mobility-related limitations in older populations. J Gerontol Med Sci. 2002;57A:M294-M301.
  197. McCusker J, Kakuma R, Abrahamowicz M. Predictors of functional decline in hospitalized elderly patients: a systematic review. J Gerontol Med Sci. 2002;57A:M569-M577.
  198. Trappe S, Williamson D, Godard M. Maintenance of whole muscle strength and size following resistance training in older men. J Gerontol Biol Sci. 2002;57A:B138-B143.
  199. Kane RA, Kling KC, Bershadsky B, et al. Quality of life measures for nursing home residents. J Gerontol Med Sci. 2003;58A:240-248.
  200. Morley JE. Anorexia and weight loss in older persons. J Gerontol Med Sci. 2003;58A:131-137.
  201. Banks WA, Morley JE. Memories are made of this: recent advances in understanding cognitive impairments and dementia. J Gerontol Med Sci. 2003;58A:314-321.
  202. Evert J, Lawler E, Bogan H, Perls T. Morbidity profiles of centenarians: survivors, delayers, and escapers. J Gerontol Med Sci. 2003;58A:232-237.
  203. Grossberg GT, Desai AK. Management of Alzheimer's disease. J Gerontol Med Sci. 2003;58A:331-353.
  204. Bodkin NL, Alexander TM, Ortmeyer HK, Johnson E, Hansen BC. Mortality and morbidity in laboratory-maintained rhesus monkeys and effects of long-term dietary restriction. J Gerontol Biol Sci. 2003;58A:212-219.
  205. Gill TM, Kurland B. The burden and patterns of disability in activities of daily living among community-living older persons. J Gerontol Med Sci. 2003;58A:70-75.
  206. Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A. Delayed occurrence of fatal neoplastic diseases in Ames dwarf mice: correlation to extended longevity. J Gerontol Biol Sci. 2003;58A:291-296.
  207. LaStayo PC, Ewy GA, Pierotti DD, Johns RK, Lindstedt S. The positive effects of negative work: increased muscle strength and decreased fall risk in a frail elderly population. J Gerontol Med Sci. 2003;58A:419-424.
  208. Whitmer RA, Haan MN, Miller JW, Yaffe K. Hormone replacement therapy and cognitive performance: the role of homocysteine. J Gerontol Med Sci. 2003;58A:324-330.
  209. Asthana S. Estrogen and cognition: the story so far. J Gerontol Med Sci. 2003;58A:322-323.
  210. Crogan NL, Pasvogel A. The influence of protein-calorie malnutrition on quality of life in nursing homes. J Gerontol Med Sci. 2003;58A:159-164.
  211. Lambert CP, Sullivan DH, Evans WJ. Megestrol acetate-induced weight gain does not negatively affect blood lipids in elderly men: effects of resistance training and testosterone replacement. J Gerontol Med Sci. 2003;58A:644-647.
  212. Miszko TA, Cress ME, Slade JM, Covery CJ, Agrawal SK, Doerr CE. Effect of strength and power training on physical function in community-dwelling older adults. J Gerontol Med Sci. 2003;58A:171-175.
  213. Bhasin S, Taylor WE, Singh R, et al. The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. J Gerontol Med Sci. 2003;58A:1103-1110.
  214. Blumenthal HT. The aging-disease dichotomy: true or false? J Gerontol Med Sci. 2003;58A:138-145.
  215. Kiely DK, Bergmann MA, Murphy KM, Jones RN, Orav EJ, Marcantonio ER. Delirium among newly admitted postacute facility patients: prevalence, symptoms, and severity. J Gerontol Med Sci. 203;58A:441-445.
  216. Sand LP, Yaffe K, Covinsky K, et al. Cognitive screening predicts magnitude of functional recovery from admission to 3 months after discharge in hospitalized elders. J Gerontol Med Sci. 2003;58A:37-45.
  217. Thomas DR. The struggle to relate epidemiology to real people [Commentary on Goodwin's "Embracing complexity: a consideration of hypertension in the very old"]. J Gerontol Med Sci. 2003;58:667-668.




This Article
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager

HOME ARCHIVE SEARCH TABLE OF CONTENTS